drugset / Trial / NCT01578057

Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol

NCT01578057

Phase 1 Completed 28 enrolled Vanda Pharmaceuticals
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this research study is to understand if there is any difference in the effects of tasimelteon when it is taken alone or in combination with alcohol. This research study is also being done to understand if there is any difference in the amount of tasimelteon (and its breakdown products) or alcohol in the blood when taken alone or together. Finally, the study will also look at the safety and tolerability (how acceptable it is) of tasimelteon.

Timeline

Start
2012-04
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified 0.6 g/kg Oral
Subject Alcohol Other / unclassified 0.7 g/kg Oral
Subject tasimelteon Small molecule 20 mg

Indications

No indication recorded.